APO Research
Talk to an analyst

APO RESEARCH · REPORT

Zika Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Zika Vaccines Market Outlook and Growth Opportunities 2026

21 December 2025192 pages

Choose your research edition.

Industry ResearchZika Vaccines Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Zika Vaccines Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Zika Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Zika Vaccines Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Zika Vaccines Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Zika Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Zika Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Zika Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Zika Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Zika Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Zika Vaccines market include Sanofi, GlaxoSmithKline, NewLink Genetics, Inovio Pharmaceuticals, Immunovaccine, Cerus Corporation and Bharat Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Zika Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Zika Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Zika Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Zika Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Zika Vaccines Segment by Company

Sanofi

GlaxoSmithKline

NewLink Genetics

Inovio Pharmaceuticals

Immunovaccine

Cerus Corporation

Bharat Biotech

Zika Vaccines Segment by Type

Therapeutic Vaccines

Preventive Vaccines

Zika Vaccines Segment by Application

Clinics

Hospitals

Ambulatory Surgery Centers

Others

Zika Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Zika Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Zika Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Zika Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Zika Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zika Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Zika Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zika Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Zika Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Zika Vaccines industry.

Chapter 3: Detailed analysis of Zika Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Zika Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Zika Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Zika Vaccines Industry Trends Table 2. Zika Vaccines Industry Drivers Table 3. Zika Vaccines Industry Opportunities and Challenges Table 4. Zika Vaccines Industry Restraints Table 5. Global Zika Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Zika Vaccines Revenue Share by Company (2021-2026) Table 7. Global Zika Vaccines Sales Volume by Company (k units) & (2021-2026) Table 8. Global Zika Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Zika Vaccines Average Price (US$/unit) of Company (2021-2026) Table 10. Global Zika Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Zika Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Zika Vaccines Company, Product Type & Application Table 13. Global Zika Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Zika Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Therapeutic Vaccines Table 18. Significant Companies of Preventive Vaccines Table 19. Global Zika Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Zika Vaccines Sales Volume by Type (2021-2026) & (k units) Table 21. Global Zika Vaccines Sales Volume by Type (2027-2032) & (k units) Table 22. Global Zika Vaccines Sales Volume Share by Type (2021-2026) Table 23. Global Zika Vaccines Sales Volume Share by Type (2027-2032) Table 24. Global Zika Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Zika Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Zika Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Zika Vaccines Sales Value Share by Type (2021-2026) Table 28. Global Zika Vaccines Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Clinics Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Ambulatory Surgery Centers Table 32. Significant Companies of Others Table 33. Global Zika Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Zika Vaccines Sales Volume by Application (2021-2026) & (k units) Table 35. Global Zika Vaccines Sales Volume by Application (2027-2032) & (k units) Table 36. Global Zika Vaccines Sales Volume Share by Application (2021-2026) Table 37. Global Zika Vaccines Sales Volume Share by Application (2027-2032) Table 38. Global Zika Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Zika Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Zika Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Zika Vaccines Sales Value Share by Application (2021-2026) Table 42. Global Zika Vaccines Sales Value Share by Application (2027-2032) Table 43. Global Zika Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Zika Vaccines Sales by Region (2021-2026) & (k units) Table 45. Global Zika Vaccines Sales Market Share by Region (2021-2026) Table 46. Global Zika Vaccines Sales by Region (2027-2032) & (k units) Table 47. Global Zika Vaccines Sales Market Share by Region (2027-2032) Table 48. Global Zika Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Zika Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Zika Vaccines Sales Value Share by Region (2021-2026) Table 51. Global Zika Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Zika Vaccines Sales Value Share by Region (2027-2032) Table 53. Global Zika Vaccines Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Zika Vaccines Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Zika Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Zika Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Zika Vaccines Sales by Country (2021-2026) & (k units) Table 58. Global Zika Vaccines Sales Market Share by Country (2021-2026) Table 59. Global Zika Vaccines Sales by Country (2027-2032) & (k units) Table 60. Global Zika Vaccines Sales Market Share by Country (2027-2032) Table 61. Global Zika Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Zika Vaccines Sales Value Market Share by Country (2021-2026) Table 63. Global Zika Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Zika Vaccines Sales Value Market Share by Country (2027-2032) Table 65. Sanofi Company Information Table 66. Sanofi Business Overview Table 67. Sanofi Zika Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Sanofi Zika Vaccines Product Portfolio Table 69. Sanofi Recent Development Table 70. GlaxoSmithKline Company Information Table 71. GlaxoSmithKline Business Overview Table 72. GlaxoSmithKline Zika Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. GlaxoSmithKline Zika Vaccines Product Portfolio Table 74. GlaxoSmithKline Recent Development Table 75. NewLink Genetics Company Information Table 76. NewLink Genetics Business Overview Table 77. NewLink Genetics Zika Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. NewLink Genetics Zika Vaccines Product Portfolio Table 79. NewLink Genetics Recent Development Table 80. Inovio Pharmaceuticals Company Information Table 81. Inovio Pharmaceuticals Business Overview Table 82. Inovio Pharmaceuticals Zika Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Inovio Pharmaceuticals Zika Vaccines Product Portfolio Table 84. Inovio Pharmaceuticals Recent Development Table 85. Immunovaccine Company Information Table 86. Immunovaccine Business Overview Table 87. Immunovaccine Zika Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Immunovaccine Zika Vaccines Product Portfolio Table 89. Immunovaccine Recent Development Table 90. Cerus Corporation Company Information Table 91. Cerus Corporation Business Overview Table 92. Cerus Corporation Zika Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Cerus Corporation Zika Vaccines Product Portfolio Table 94. Cerus Corporation Recent Development Table 95. Bharat Biotech Company Information Table 96. Bharat Biotech Business Overview Table 97. Bharat Biotech Zika Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Bharat Biotech Zika Vaccines Product Portfolio Table 99. Bharat Biotech Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Zika Vaccines Distributors List Table 103. Zika Vaccines Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Zika Vaccines Product Image Figure 2. Global Zika Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Zika Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Zika Vaccines Sales (2021-2032) & (k units) Figure 5. Global Zika Vaccines Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Zika Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Therapeutic Vaccines Image Figure 10. Preventive Vaccines Image Figure 11. Global Zika Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Zika Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Zika Vaccines Sales Volume Share by Type (2021-2032) Figure 14. Global Zika Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Zika Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Zika Vaccines Sales Value Share by Type (2021-2032) Figure 17. Clinics Image Figure 18. Hospitals Image Figure 19. Ambulatory Surgery Centers Image Figure 20. Others Image Figure 21. Global Zika Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Zika Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Zika Vaccines Sales Volume Share by Application (2021-2032) Figure 24. Global Zika Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Zika Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Zika Vaccines Sales Value Share by Application (2021-2032) Figure 27. Global Zika Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Zika Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Zika Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Zika Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Zika Vaccines Sales Value (2021-2032) & (US$ Million) Figure 32. North America Zika Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Zika Vaccines Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Zika Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Zika Vaccines Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Zika Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Zika Vaccines Sales Value (2021-2032) & (US$ Million) Figure 38. South America Zika Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Zika Vaccines Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Zika Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Zika Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Zika Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Zika Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Zika Vaccines Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Zika Vaccines Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Therapeutic Vaccines
  • Preventive Vaccines
Applications
  • Clinics
  • Hospitals
  • Ambulatory Surgery Centers
  • Others
Companies covered
  • Sanofi
  • GlaxoSmithKline
  • NewLink Genetics
  • Inovio Pharmaceuticals
  • Immunovaccine
  • Cerus Corporation
  • Bharat Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Zika Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Zika Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Zika Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Zika Vaccines Market Dynamics
  1. 2.1 Zika Vaccines Industry Trends
  2. 2.2 Zika Vaccines Industry Drivers
  3. 2.3 Zika Vaccines Industry Opportunities and Challenges
  4. 2.4 Zika Vaccines Industry Restraints
3 Zika Vaccines Market by Company
  1. 3.1 Global Zika Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Zika Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Zika Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Zika Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Zika Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Zika Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Zika Vaccines Company Product Type and Application
  8. 3.8 Global Zika Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Zika Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Zika Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Zika Vaccines Market by Type
  1. 4.1 Zika Vaccines Type Introduction
  2. 4.1.1 Therapeutic Vaccines
  3. 4.1.2 Preventive Vaccines
  4. 4.2 Global Zika Vaccines Sales Volume by Type
  5. 4.2.1 Global Zika Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Zika Vaccines Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Zika Vaccines Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Zika Vaccines Sales Value by Type
  9. 4.3.1 Global Zika Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Zika Vaccines Sales Value by Type (2021-2032)
  11. 4.3.3 Global Zika Vaccines Sales Value Share by Type (2021-2032)
5 Zika Vaccines Market by Application
  1. 5.1 Zika Vaccines Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Ambulatory Surgery Centers
  5. 5.1.4 Others
  6. 5.2 Global Zika Vaccines Sales Volume by Application
  7. 5.2.1 Global Zika Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Zika Vaccines Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Zika Vaccines Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Zika Vaccines Sales Value by Application
  11. 5.3.1 Global Zika Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Zika Vaccines Sales Value by Application (2021-2032)
  13. 5.3.3 Global Zika Vaccines Sales Value Share by Application (2021-2032)
6 Zika Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Zika Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Zika Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Zika Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Zika Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Zika Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Zika Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Zika Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Zika Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Zika Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Zika Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Zika Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Zika Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Zika Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Zika Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Zika Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Zika Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Zika Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Zika Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Zika Vaccines Sales Value Share by Country, 2025 VS 2032
7 Zika Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Zika Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Zika Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Zika Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Zika Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Zika Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Zika Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Zika Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Zika Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Zika Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Zika Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Zika Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Zika Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Zika Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Zika Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Zika Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Zika Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Zika Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Zika Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Zika Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Zika Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Zika Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Zika Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Zika Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Zika Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Zika Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Zika Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Zika Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Zika Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Zika Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Zika Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Zika Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Zika Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Zika Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Zika Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Zika Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Zika Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Zika Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Zika Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Zika Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Zika Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Zika Vaccines Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 GlaxoSmithKline
  8. 8.2.1 GlaxoSmithKline Company Information
  9. 8.2.2 GlaxoSmithKline Business Overview
  10. 8.2.3 GlaxoSmithKline Zika Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 GlaxoSmithKline Zika Vaccines Product Portfolio
  12. 8.2.5 GlaxoSmithKline Recent Developments
  13. 8.3 NewLink Genetics
  14. 8.3.1 NewLink Genetics Company Information
  15. 8.3.2 NewLink Genetics Business Overview
  16. 8.3.3 NewLink Genetics Zika Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 NewLink Genetics Zika Vaccines Product Portfolio
  18. 8.3.5 NewLink Genetics Recent Developments
  19. 8.4 Inovio Pharmaceuticals
  20. 8.4.1 Inovio Pharmaceuticals Company Information
  21. 8.4.2 Inovio Pharmaceuticals Business Overview
  22. 8.4.3 Inovio Pharmaceuticals Zika Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Inovio Pharmaceuticals Zika Vaccines Product Portfolio
  24. 8.4.5 Inovio Pharmaceuticals Recent Developments
  25. 8.5 Immunovaccine
  26. 8.5.1 Immunovaccine Company Information
  27. 8.5.2 Immunovaccine Business Overview
  28. 8.5.3 Immunovaccine Zika Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Immunovaccine Zika Vaccines Product Portfolio
  30. 8.5.5 Immunovaccine Recent Developments
  31. 8.6 Cerus Corporation
  32. 8.6.1 Cerus Corporation Company Information
  33. 8.6.2 Cerus Corporation Business Overview
  34. 8.6.3 Cerus Corporation Zika Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Cerus Corporation Zika Vaccines Product Portfolio
  36. 8.6.5 Cerus Corporation Recent Developments
  37. 8.7 Bharat Biotech
  38. 8.7.1 Bharat Biotech Company Information
  39. 8.7.2 Bharat Biotech Business Overview
  40. 8.7.3 Bharat Biotech Zika Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bharat Biotech Zika Vaccines Product Portfolio
  42. 8.7.5 Bharat Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Zika Vaccines Value Chain Analysis
  2. 9.1.1 Zika Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Zika Vaccines Sales Mode & Process
  6. 9.2 Zika Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Zika Vaccines Distributors
  9. 9.2.3 Zika Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst